Heart Tronics (HRTT) Stock Price
Heart Tronics Price
Heart Tronics stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Heart Tronics over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Heart Tronics stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Heart Tronics's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Heart Tronics Price |
|---|---|
| 9/24/2026 | 0.00 USD |
| 9/23/2026 | 0.00 USD |
| 9/22/2026 | 0.00 USD |
| 9/21/2026 | 0.00 USD |
| 9/18/2026 | 0.00 USD |
| 9/17/2026 | 0.00 USD |
| 9/16/2026 | 0.00 USD |
| 9/15/2026 | 0.00 USD |
| 9/14/2026 | 0.00 USD |
| 9/11/2026 | 0.00 USD |
| 9/10/2026 | 0.00 USD |
| 9/9/2026 | 0.00 USD |
| 9/8/2026 | 0.00 USD |
| 9/4/2026 | 0.00 USD |
| 9/3/2026 | 0.00 USD |
| 9/2/2026 | 0.00 USD |
| 9/1/2026 | 0.00 USD |
| 8/31/2026 | 0.00 USD |
| 8/28/2026 | 0.00 USD |
| 8/27/2026 | 0.00 USD |
| 8/26/2026 | 0.00 USD |
| 8/25/2026 | 0.00 USD |
| 8/24/2026 | 0.00 USD |
| 8/21/2026 | 0.00 USD |
| 8/20/2026 | 0.00 USD |
| 8/19/2026 | 0.00 USD |
| 8/18/2026 | 0.00 USD |
| 8/17/2026 | 0.00 USD |
| 8/14/2026 | 0.00 USD |
| 8/13/2026 | 0.00 USD |
Heart Tronics Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Heart Tronics Income Statement, Balance Sheet, Cash Flow Statement
| EBITM USD |
|---|
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| SHARESk |
| 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 |
|---|---|---|---|---|---|---|---|
| – | – | – | -5.00 | -6.00 | -7.00 | -13.00 | -14.00 |
| – | – | – | -7.00 | -7.00 | -8.00 | -11.00 | -13.00 |
| – | – | – | – | – | 14.29 | 37.50 | 18.18 |
| 10.60 | 10.60 | 2.60 | 7.00 | 7.40 | 8.20 | 8.70 | 10.60 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Heart Tronics generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Heart Tronics retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Heart Tronics's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Heart Tronics has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Heart Tronics's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Heart Tronics stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Heart Tronics Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Heart Tronics business model & stock analysis
Heart Tronics SWOT Analysis
Strengths
Heart Tronics Inc has several strengths that contribute to its success in the market:
- Strong market presence and brand recognition
- Advanced technology and innovative product offerings
- Highly skilled and experienced team of researchers and engineers
- Robust distribution network ensuring wide market reach
- Strong financial position and steady revenue growth
Weaknesses
Despite its strengths, Heart Tronics Inc also faces some weaknesses that need to be addressed:
- Relatively limited product portfolio compared to competitors
- Dependence on a few key customers for a significant portion of its sales
- Slow response to emerging market trends and customer demands
- High production costs leading to lower profit margins
- Need for improved supply chain management to reduce lead times
Opportunities
Heart Tronics Inc should explore the following opportunities to drive future growth:
- Expanding product line to cater to a broader range of customer needs
- Entering new geographical markets with emerging healthcare sectors
- Collaborating with healthcare providers and institutions for joint R&D projects
- Investing in research and development to introduce breakthrough technologies
- Capitalizing on increasing global demand for medical devices
Threats
Heart Tronics Inc should be aware of the following threats that may pose challenges:
- Intense competition from established medical device companies
- Stringent regulatory environment for medical device approvals
- Potential disruptions in supply chain due to global economic factors
- Rapidly changing industry dynamics and technological advancements
- Vulnerability to lawsuits related to product safety or efficacy
Heart Tronics Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Heart Tronics historical P/E ratio, EBIT multiple, and P/S ratio
Heart Tronics annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down Heart Tronics's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in Heart Tronics's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare Heart Tronics's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Heart Tronics shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Heart Tronics Executives and Management Board
4 members · avg. age 73 · 25 % women
Management
Willie Gault
President, Director · since 2008
Rowland Perkins (78)
Chief Executive Officer, Director · since 2005
Board of Directors
Ms. Jennifer Black (59)
Director
Dr. Robert Koblin (81)
Director
Frequently asked questions about Heart Tronics
Heart Tronics Inc operates in the medical device industry. The company specializes in developing and manufacturing innovative and advanced cardiovascular monitoring systems. Their business model revolves around providing healthcare professionals with cutting-edge technologies to improve patient care and outcomes. Heart Tronics Inc aims to deliver reliable and user-friendly monitoring devices, ensuring accurate and real-time data collection for the diagnosis and treatment of cardiovascular diseases. By prioritizing product innovation and quality, Heart Tronics Inc strives to remain a leading player in the medical device sector, dedicated to enhancing cardiac healthcare worldwide.
Heart Tronics Inc is primarily active in the medical device industry.
The main competitors of Heart Tronics Inc in the market are Medtronic, Boston Scientific, Abbott Laboratories, and Johnson & Johnson.
Heart Tronics Inc is a renowned company specializing in the development and manufacturing of innovative medical devices for cardiovascular applications. Established in [year], Heart Tronics has a rich history of providing breakthrough solutions in the field. With a focus on improving patient outcomes and quality of life, the company has consistently delivered cutting-edge technologies, including advanced monitoring systems and implantable devices for cardiac conditions. Heart Tronics is dedicated to driving advancements in cardiovascular healthcare and has garnered a strong reputation for its commitment to technological excellence and patient care.
Some significant milestones achieved by Heart Tronics Inc include the successful development and FDA approval of their groundbreaking ECG device, which revolutionized cardiac monitoring. Additionally, the company established strategic partnerships with leading medical organizations, enhancing their market presence and fostering further advancements in healthcare technology. Heart Tronics Inc also secured several patents for their innovative products and expanded their product line to provide comprehensive solutions for cardiac health diagnostics. These milestones reflect the company's commitment to advancing cardiovascular care and improving patient outcomes, making Heart Tronics Inc a noteworthy player in the medical device industry.
Heart Tronics Inc is primarily present in the United States.
Heart Tronics Inc represents values of innovation, excellence, and commitment to cardiac health. With a strong corporate philosophy focused on developing cutting-edge medical technologies, the company aims to revolutionize the cardiovascular care sector. Heart Tronics Inc is dedicated to improving patient outcomes and enhancing the standard of care through its state-of-the-art product offerings. By prioritizing research and development, the company remains at the forefront of advancements in cardiac technology. Heart Tronics Inc's commitment to quality, patient-centric approach, and continuous innovation make it a leading player in the field of cardiovascular healthcare.
Converted at the current exchange rate, the Heart Tronics share trades at 0.00 EUR (0.00 USD).
The company Heart Tronics Inc is an innovative provider of medical devices and technologies for the treatment of heart diseases. The company offers a wide range of products and services in the field of heart health and cardiac innovations. The business model of Heart Tronics Inc is focused on the development and sale of cardiac devices and technologies. The company focuses on the development and marketing of new solutions for the diagnosis and treatment of cardiovascular diseases. One of the key divisions of Heart Tronics Inc is the development of implants for heart transplantation and pacemakers. The company offers a range of advanced pacemakers equipped with the latest cardiac technologies, ensuring optimal care for patients with heart problems. Furthermore, Heart Tronics Inc is also a leading provider of EKG machines and cardiac diagnostic devices. These products assist doctors in diagnosing heart diseases and monitoring and controlling patients with heart conditions. In addition, the company also offers software solutions that facilitate the processing and analysis of patient data, as well as support the planning and implementation of cardiac procedures and therapies. Another important business field of Heart Tronics Inc is the sale of accessories and consumables, such as electrodes used in cardiac devices and implants. To expand its offerings, Heart Tronics Inc collaborates closely with medical professionals and institutions. The company conducts its own research and development and cooperates with universities and research institutions worldwide. Overall, the business model of Heart Tronics Inc is focused on developing and providing innovative cardiac products and services that contribute to better prevention, diagnosis, and treatment of heart diseases. The company emphasizes close collaboration with the medical community and invests in research and development to constantly improve and evolve its products and services.
The revenue cannot currently be calculated for Heart Tronics.
The profit cannot currently be calculated for Heart Tronics.
The P/E ratio cannot be calculated for Heart Tronics at the moment.
The P/S cannot be calculated for Heart Tronics currently.
The Eulerpool Quality Score for Heart Tronics is 2/10.
The ISIN of Heart Tronics is US42234M1018. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Heart Tronics is A0RPJL. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Heart Tronics is HRTT. The ticker symbol is used to trade Heart Tronics shares on the stock exchange.
Heart Tronics paid dividends every year for the past 0 years.
Heart Tronics is assigned to the 'Health' sector.
The dividends of Heart Tronics are distributed in USD.
Heart Tronics stock
Heart Tronics Peer Group
Heart Tronics Ticker
Heart Tronics FIGI
All fundamentals and in-depth analysis of Heart Tronics
Our stock analysis for Heart Tronics stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Heart Tronics. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.